Exenatide (exendin-4) studies: 530 papers with results
Page 6 of 11
- Effect of exenatide on the steady-state pharmacokinetics of digoxin.
Kothare PA · Journal of clinical pharmacology · 2005
Non-randomized trial · 6 results
- Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.
Sze L · The Journal of clinical endocrinology and metabolism · 2011
Non-randomized trial · 10 results
- Alterations in energy balance following exenatide administration.
Bradley DP · Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme · 2012
Non-randomized trial · 8 results
- Acute metabolic effects of exenatide in patients with type 1 diabetes with and without residual insulin to oral and intravenous glucose challenges.
Ghazi T · Diabetes care · 2014
Non-randomized trial · 6 results
- Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men.
Soon D · Journal of clinical pharmacology · 2006
Non-randomized trial · 4 results
- Effect of renal impairment on the pharmacokinetics of exenatide.
Linnebjerg H · British journal of clinical pharmacology · 2007
Non-randomized trial · 11 results
- Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic positron emission tomography study.
Gastaldelli A · Hepatology (Baltimore, Md.) · 2016
Non-randomized trial · 8 results
- Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes.
Fehse F · The Journal of clinical endocrinology and metabolism · 2005
Non-randomized trial · 5 results
- Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
Cervera A · American journal of physiology. Endocrinology and metabolism · 2008
Non-randomized trial · 11 results
- Effect of exenatide on splanchnic and peripheral glucose metabolism in type 2 diabetic subjects.
Cersosimo E · The Journal of clinical endocrinology and metabolism · 2011
Non-randomized trial · 16 results
- Day-long subcutaneous infusion of exenatide lowers glycemia in patients with type 2 diabetes.
Taylor K · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2005
Non-randomized trial · 8 results
- Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes.
Ghofaili KA · Transplantation · 2007
Non-randomized trial · 9 results
- Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.
Faradji RN · Cell transplantation · 2009
Non-randomized trial · 14 results
- Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men.
Muskiet MH · Diabetes, obesity & metabolism · 2016
Non-randomized trial · 12 results
- Effects of 1-mo bolus subcutaneous administration of exendin-4 in type 2 diabetes.
Egan JM · American journal of physiology. Endocrinology and metabolism · 2003
Non-randomized trial · 4 results
- Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome.
Salehi P · Pediatric obesity · 2017
Non-randomized trial · 6 results
- Exenatide acutely increases heart rate in parallel with augmented sympathetic nervous system activation in healthy overweight males.
Smits MM · British journal of clinical pharmacology · 2016
Non-randomized trial · 7 results
- Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes.
Dupré J · The Journal of clinical endocrinology and metabolism · 2004
Non-randomized trial · 6 results
- A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity.
Lomenick JP · Obesity (Silver Spring, Md.) · 2016
Non-randomized trial · 5 results
- Diurnal glucose patterns of exenatide once weekly: a 1-year study using continuous glucose monitoring with ambulatory glucose profile analysis.
Mazze R · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2009
Non-randomized trial · 7 results
- The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes.
Egan JM · The Journal of clinical endocrinology and metabolism · 2002
Non-randomized trial · 5 results
- Effects of exenatide on systolic blood pressure in subjects with type 2 diabetes.
Okerson T · American journal of hypertension · 2010
Non-randomized trial · 9 results
- Pharmacokinetics and pharmacodynamics of exenatide extended-release after single and multiple dosing.
Fineman M · Clinical pharmacokinetics · 2011
Non-randomized trial · 12 results
- DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide.
Wysham C · Diabetic medicine : a journal of the British Diabetic Association · 2011
Non-randomized trial · 14 results
- Long-term insulin independence and improvement in insulin secretion after supplemental islet infusion under exenatide and etanercept.
Faradji RN · Transplantation · 2008
Non-randomized trial · 7 results
- Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes.
Henry RR · Journal of diabetes and its complications · 2014
Non-randomized trial · 8 results
- Exenatide induces frataxin expression and improves mitochondrial function in Friedreich ataxia.
Igoillo-Esteve M · JCI insight · 2020
Non-randomized trial · 10 results
- Clinical and economic outcomes in patients with type 2 diabetes initiating insulin glargine disposable pen versus exenatide BID.
Baser O · Journal of medical economics · 2011
Observational study · 7 results
- Metabolic measures 12 months after a randomised controlled trial of treatment of clozapine associated obesity and diabetes with exenatide (CODEX).
Siskind D · Journal of psychiatric research · 2020
Observational study · 10 results
- High baseline FGF21 levels are associated with poor glucose-lowering efficacy of exenatide in patients with type 2 diabetes.
Yang K · Acta diabetologica · 2021
Observational study · 4 results
- Post hoc analysis of the Exenatide-PD trial-Factors that predict response.
Athauda D · The European journal of neuroscience · 2019
Observational study · 4 results
- Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide.
Dore DD · Current medical research and opinion · 2009
Observational study · 2 results
- Observational study of kidney function and albuminuria in patients with type 2 diabetes treated with exenatide BID versus insulin glargine.
Pawaskar M · The Annals of pharmacotherapy · 2014
Observational study · 2 results
- Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis.
Sheu WH · Diabetes research and clinical practice · 2016
Observational study · 17 results
- Retrospective real-world adherence in patients with type 2 diabetes initiating once-daily liraglutide 1.8 mg or twice-daily exenatide 10 μg.
Malmenäs M · Clinical therapeutics · 2013
Observational study · 4 results
- Six-month outcomes on A1C and cardiovascular risk factors in patients with type 2 diabetes treated with exenatide in an ambulatory care setting.
Brixner DI · Diabetes, obesity & metabolism · 2009
Observational study · 8 results
- Reduced daily risk of glycemic variability: comparison of exenatide with insulin glargine.
McCall AL · Diabetes technology & therapeutics · 2009
Observational study · 5 results
- One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice.
Buysschaert M · Diabetes & metabolism · 2010
Observational study · 14 results
- Improved glycemic control and reduction of cardiometabolic risk factors in subjects with type 2 diabetes and metabolic syndrome treated with exenatide in a clinical practice setting.
Bhushan R · Diabetes technology & therapeutics · 2009
Observational study · 11 results
- Exenatide therapy in insulin-treated type 2 diabetes and obesity.
Nayak UA · QJM : monthly journal of the Association of Physicians · 2010
Observational study · 7 results
- Durability of effects of exenatide treatment on glycemic control, body weight, systolic blood pressure, C-reactive protein, and triglyceride concentrations.
Varanasi A · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2011
Observational study · 14 results
- Safety and efficacy of exenatide in combination with insulin in patients with type 2 diabetes mellitus.
Sheffield CA · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2008
Observational study · 9 results
- Determining predictors of early response to exenatide in patients with type 2 diabetes mellitus.
Khan M · Journal of diabetes research · 2015
Observational study · 5 results
- Exenatide therapy in obese patients with type 2 diabetes mellitus treated with insulin.
Viswanathan P · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2007
Observational study · 8 results
- Once-weekly exenatide as adjunct treatment of type 1 diabetes mellitus in patients receiving continuous subcutaneous insulin infusion therapy.
Traina AN · Canadian journal of diabetes · 2014
Observational study · 5 results
- Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis.
Garg R · Diabetes care · 2010
Observational study · 2 results
- Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database.
Best JH · Diabetes care · 2011
Observational study · 3 results
- Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: results from an observational research.
Irace C · Diabetes & vascular disease research · 2013
Observational study · 1 result
- Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine.
Fabunmi R · Current medical research and opinion · 2009
Observational study · 5 results
- Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION-8 study.
Jabbour SA · Diabetes, obesity & metabolism · 2018
Observational study · 7 results